scholarly article | Q13442814 |
P50 | author | Seth M Daly | Q53678235 |
Chris W Diehnelt | Q59755737 | ||
P2093 | author name string | Stephen Albert Johnston | |
John C Lainson | |||
Pamela R Hall | |||
Kathleen Triplett | |||
P2860 | cites work | Immunosignaturing can detect products from molecular markers in brain cancer | Q21134151 |
Roles of d-Amino Acids on the Bioactivity of Host Defense Peptides | Q26744734 | ||
Synergy among antibacterial peptides and between peptides and small-molecule antibiotics | Q33593511 | ||
Multivalent Antimicrobial Peptides as Therapeutics: Design Principles and Structural Diversities | Q34098551 | ||
A technology for developing synbodies with antibacterial activity | Q34570999 | ||
Platforms for antibiotic discovery | Q34694926 | ||
Iterative antimicrobial candidate selection from informed d-/l-Peptide dimer libraries | Q35024514 | ||
Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals? | Q35173769 | ||
Precision-guided antimicrobial peptide as a targeted modulator of human microbial ecology | Q35649455 | ||
Whole-Virus Screening to Develop Synbodies for the Influenza Virus | Q36141560 | ||
APD3: the antimicrobial peptide database as a tool for research and education | Q36434966 | ||
Targeted Treatment for Bacterial Infections: Prospects for Pathogen-Specific Antibiotics Coupled with Rapid Diagnostics | Q37087480 | ||
Design and activity of a 'dual-targeted' antimicrobial peptide | Q37228730 | ||
Daptomycin inhibits cell envelope synthesis by interfering with fluid membrane microdomains. | Q37417749 | ||
Inactivation of a bacterial virulence pheromone by phagocyte-derived oxidants: new role for the NADPH oxidase in host defense | Q37535453 | ||
Beyond natural antimicrobial peptides: multimeric peptides and other peptidomimetic approaches. | Q37877621 | ||
Targeting antimicrobial-resistant bacterial respiratory tract pathogens: it is time to 'get smart'. | Q38382308 | ||
Mechanisms of Methicillin Resistance in Staphylococcus aureus | Q38512695 | ||
Resistance to Non-glycopeptide Agents in Serious Staphylococcus aureus Infections | Q39016281 | ||
Contribution of linker stability to the activities of anticancer immunoconjugates | Q40006635 | ||
Conjugation Approach To Produce a Staphylococcus aureus Synbody with Activity in Serum | Q40544376 | ||
N-Lipidated Peptide Dimers: Effective Antibacterial Agents against Gram-Negative Pathogens through Lipopolysaccharide Permeabilization | Q41088368 | ||
Dimeric unnatural polyproline-rich peptides with enhanced antibacterial activity | Q42139887 | ||
Simultaneous breakdown of multiple antibiotic resistance mechanisms in S. aureus | Q46700320 | ||
Fibrinogen Depletion Attenuates Staphyloccocus aureus Infection by Preventing Density-Dependent Virulence Gene Up-Regulation | Q47395178 | ||
Public health dispatch: outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections--Los Angeles County, California, 2002-2003 | Q73564276 | ||
P433 | issue | 8 | |
P304 | page(s) | 853-857 | |
P577 | publication date | 2017-07-07 | |
P1433 | published in | ACS Medicinal Chemistry Letters | Q2819061 |
P1476 | title | Synthetic Antibacterial Peptide Exhibits Synergy with Oxacillin against MRSA | |
P478 | volume | 8 |
Q92441701 | Antibiotic resistance breakers: current approaches and future directions |
Q98243294 | Cationic amphiphilic peptide: A nature-inspired synthetic antimicrobial peptide |
Q92857473 | Combinatory Therapy Antimicrobial Peptide-Antibiotic to Minimize the Ongoing Rise of Resistance |
Q92110440 | Repurposing Azithromycin and Rifampicin Against Gram-Negative Pathogens by Combination With Peptidomimetics |
Q90668664 | The synthetic and therapeutic expedition of isoxazole and its analogs |
Search more.